a brown pharmacy building on a concrete lot on an overcast day

March 17, 2025: A Texas Pharmacist gets 17 years for $145m skin cream billing fraud

March 18, 2025

A Texas man billed government programs millions for creams compounded by untrained teenagers. News about counterfeit medicine in six U.S. states.

Read More
Vials of black market weight loss drugs

March 10, 2025: Patients transitioning from compounded diabetes / weight loss injections: Stick to licensed sources

March 10, 2025

FDA’s shutdown of GLP-1 compounding could lead to a new era of risk for U.S. patients.

Read More

FDA Alert: Update on Previous Nationwide Warning About Presence of Undeclared API in Capsules

March 10, 2025

The FDA published an update to a previous alert about undeclared active pharmaceutical ingredients in a dietary supplement to expand the package styles affected by this warning.

Read More

FDA Alert: Recall Issued on Nasal Wash System Due to Microbial Contamination

March 4, 2025

An FDA alert shared information on a nationwide recall of a nasal wash system due to microbrial contamination.

Read More

FDA Alert: Recall Issued on Injectable Product Due to Potential Particulate Matter

March 4, 2025

An FDA alert warned that Central Admixture Pharmacy Services issued a nationwide recall of Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag due to the detection of black particulate matter in a single sealed vial of Phenylephrine Hydrochloride.

Read More

FDA Alert: Recall Issued on Dietary Supplement Containing Active Pharmaceutical Ingredient

March 4, 2025

An FDA alert warned that Vitafer-L has been found to contain undeclared tadalafil, an active pharmaceutical ingredient. Products containing tadalafil cannot be marketed as dietary supplements.

Read More
Boxes labeled Keytruda 50mg stacked on a white surface

March 3, 2025: Men who allegedly sold fake cancer drugs arraigned in Washington State

March 3, 2025

The U.S. Attorney’s Office in the Western District of Washington has charged two Indian nationals with selling Americans counterfeit Keytruda.

Read More
A thumbnail of the first page to Senators Marshall and Durbin.

Hims and Hers warns investors about potential liability for FDA-regulated compounded prescription drug ads

February 28, 2025

There has been controversy about the ad Hims & Hers ran during the Super Bowl. And now an SEC filing says investors should be warned about risk if their ads are found to be non-compliant.

Read More

FDA Alert: Dietary Supplement Recalled for Containing Prescription Drug Ingredients

February 26, 2025

This is a reprint of an FDA Alert.

Read More

February 24, 2025: PSM report finds 80% of declared, unapproved semaglutide and tirzepatide slipped past customs over 17 months

February 25, 2025

PSM’s new report shows that unregulated semaglutide and tirzepatide are slipping by FDA and CBP at the border. Semaglutide is no longer in shortage.

Read More